durvalumab (imfinzi) Report issue

Biologics mAb Approved FDA Accelerated Approval FDA
AACT ChEMBL DrugBank Drugs@FDA
Back

Drug Pricing Summary

VA Big4

$5.4193 - $5.4295

VA FSS

$7.1762 - $7.1763

AUS PBS

$739.6362 - $3081.8175

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
durvalumab 120 mg / 2.4 mL (2.4 mL INJECTION) $5.4193 VA Big4
  • IMFINZI (120)
    		•  ASTRAZENECA PHARMACEUTICALS LP
    durvalumab 120 mg / 2.4 mL (2.4 mL INJECTION) $7.1763 VA FSS
  • IMFINZI (120)
    		•  ASTRAZENECA PHARMACEUTICALS LP
    durvalumab 120 mg / 2.4 mL (2.4 mL INJECTION) $739.6362 AUS PBS generic
  • Imfinzi (1)
    		•  AstraZeneca Pty Ltd
    durvalumab 500 mg / 10 mL (10 mL INJECTION) $5.4295 VA Big4
  • IMFINZI (500)
    		•  ASTRAZENECA PHARMACEUTICALS LP
    durvalumab 500 mg / 10 mL (10 mL INJECTION) $7.1762 VA FSS
  • IMFINZI (500)
    		•  ASTRAZENECA PHARMACEUTICALS LP
    durvalumab 500 mg / 10 mL (10 mL INJECTION) $3081.8175 AUS PBS generic
  • Imfinzi (1)
    		•  AstraZeneca Pty Ltd

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue